InMode [INMD] vs Conmed [CNMD] Detailed Stock Comparison
InMode
NASDAQ
Loading...
Conmed
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: InMode wins in 13 metrics, Conmed wins in 6 metrics, with 0 ties. InMode appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | InMode | Conmed | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 5.91 | 14.42 | InMode |
| Price-to-Book Ratio | 1.42 | 1.58 | InMode |
| Debt-to-Equity Ratio | 0.97 | 87.93 | InMode |
| PEG Ratio | 6.64 | 10.55 | InMode |
| EV/EBITDA | 3.34 | 11.38 | InMode |
| Profit Margin (TTM) | 44.50% | 8.31% | InMode |
| Operating Margin (TTM) | 23.93% | 10.62% | InMode |
| EBITDA Margin (TTM) | 23.93% | 10.62% | InMode |
| Return on Equity | 25.91% | 11.69% | InMode |
| Return on Assets (TTM) | 9.14% | 4.03% | InMode |
| Free Cash Flow (TTM) | $132.00M | $153.88M | Conmed |
| Dividend Yield | N/A | 1.15% | N/A |
| 1-Year Return | -13.28% | -20.41% | InMode |
| Price-to-Sales Ratio (TTM) | 2.21 | 1.19 | Conmed |
| Enterprise Value | $385.38M | $2.50B | Conmed |
| EV/Revenue Ratio | 0.96 | 1.89 | InMode |
| Gross Profit Margin (TTM) | 79.97% | 55.01% | InMode |
| Revenue per Share (TTM) | $6 | $43 | Conmed |
| Earnings per Share (Diluted) | $2.38 | $3.54 | Conmed |
| Beta (Stock Volatility) | 1.93 | 1.17 | Conmed |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
InMode vs Conmed Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| InMode | -1.95% | 5.20% | -4.83% | 1.05% | -20.34% | -15.27% |
| Conmed | 2.44% | 4.36% | 2.79% | -4.70% | -19.64% | -20.74% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| InMode | -13.28% | -62.20% | -11.29% | 99.43% | 99.43% | 99.43% |
| Conmed | -20.41% | -48.25% | -37.31% | -4.80% | 171.79% | 83.88% |
Performance & Financial Health Analysis: InMode vs Conmed
| Metric | INMD | CNMD |
|---|---|---|
| Market Information | ||
| Market Cap | $889.35M | $1.58B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,222,050 | 560,860 |
| 90 Day Avg. Volume | 1,557,887 | 501,800 |
| Last Close | $14.09 | $54.68 |
| 52 Week Range | $13.14 - $19.85 | $46.00 - $78.19 |
| % from 52W High | -29.02% | -30.07% |
| All-Time High | $99.27 (Nov 01, 2021) | $159.11 (Nov 01, 2021) |
| % from All-Time High | -85.81% | -65.63% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.11% | 0.03% |
| Quarterly Earnings Growth | 0.12% | -0.29% |
| Financial Health | ||
| Profit Margin (TTM) | 0.45% | 0.08% |
| Operating Margin (TTM) | 0.24% | 0.11% |
| Return on Equity (TTM) | 0.26% | 0.12% |
| Debt to Equity (MRQ) | 0.97 | 87.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.94 | $32.41 |
| Cash per Share (MRQ) | $8.07 | $1.10 |
| Operating Cash Flow (TTM) | $104.61M | $165.21M |
| Levered Free Cash Flow (TTM) | $39.67M | $163.74M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.15% |
| Last 12-Month Dividend | N/A | $0.60 |
Valuation & Enterprise Metrics Analysis: InMode vs Conmed
| Metric | INMD | CNMD |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 5.91 | 14.42 |
| Forward P/E | 6.64 | 10.55 |
| PEG Ratio | 6.64 | 10.55 |
| Price to Sales (TTM) | 2.21 | 1.19 |
| Price to Book (MRQ) | 1.42 | 1.58 |
| Market Capitalization | ||
| Market Capitalization | $889.35M | $1.58B |
| Enterprise Value | $385.38M | $2.50B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.96 | 1.89 |
| Enterprise to EBITDA | 3.34 | 11.38 |
| Risk & Other Metrics | ||
| Beta | 1.93 | 1.17 |
| Book Value per Share (MRQ) | $9.94 | $32.41 |
Financial Statements Comparison: InMode vs Conmed
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | INMD | CNMD |
|---|---|---|
| Revenue/Sales | $77.87M | $321.26M |
| Cost of Goods Sold | $16.96M | $143.50M |
| Gross Profit | $60.91M | $177.75M |
| Research & Development | $2.90M | $12.95M |
| Operating Income (EBIT) | $15.62M | $15.96M |
| EBITDA | $15.79M | $34.21M |
| Pre-Tax Income | $22.48M | $7.67M |
| Income Tax | $4.28M | $1.64M |
| Net Income (Profit) | $18.20M | $6.04M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | INMD | CNMD |
|---|---|---|
| Cash & Equivalents | $145.95M | $35.49M |
| Total Current Assets | $634.64M | $639.00M |
| Total Current Liabilities | $72.66M | $283.15M |
| Long-Term Debt | $5.59M | $891.44M |
| Total Shareholders Equity | $619.43M | $977.64M |
| Retained Earnings | N/A | $560.13M |
| Property, Plant & Equipment | $11.37M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | INMD | CNMD |
|---|---|---|
| Operating Cash Flow | $14.14M | $49.72M |
| Capital Expenditures | $-85,000 | $-3.78M |
| Free Cash Flow | $13.96M | $37.76M |
| Debt Repayment | N/A | $-180.59M |
| Common Stock Repurchase | $-99.96M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | INMD | CNMD |
|---|---|---|
| Shares Short | 3.31M | 2.11M |
| Short Ratio | 1.86 | 4.86 |
| Short % of Float | 0.06% | 0.09% |
| Average Daily Volume (10 Day) | 1,222,050 | 560,860 |
| Average Daily Volume (90 Day) | 1,557,887 | 501,800 |
| Shares Outstanding | 69.56M | 30.90M |
| Float Shares | 53.52M | 30.68M |
| % Held by Insiders | 0.15% | 0.01% |
| % Held by Institutions | 0.71% | 1.17% |
Dividend Analysis & Yield Comparison: InMode vs Conmed
| Metric | INMD | CNMD |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.60 |
| Last 12-Month Dividend Yield | N/A | 1.15% |
| 3-Year Avg Annual Dividend | N/A | $0.73 |
| 3-Year Avg Dividend Yield | N/A | 0.24% |
| 3-Year Total Dividends | N/A | $2.20 |
| Ex-Dividend Date | N/A | Mar 14, 2025 |